AK Adjutant vs NephX
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
AK Adjutant
This medical app assists healthcare professionals in selecting anticoagulants for conditions like AF, PE, and DVT. It streamlines decision-making by calculating complex variables and comparing patient data against multiple scales and formulas. The app also offers educational resources for students and simplified tools for patient self-monitoring.
- Anticoagulant selection for AF, PE, DVT
- Calculates multiple medical scales and formulas
- Analyzes DOAC interactions with therapy
- Models complex patient scenarios
- Provides text-based recommendations
- Offline functionality
Read full descriptionHide full description
For doctors: - When choosing an anticoagulant for AF, it speeds up the decision-making process several times. This speed is achieved by using complex variables and all related parameters of all scales and formulas (Cockcroft-Gault, CKD-EPI, HAS-BLED, CHA2DS-VA, ATRIA) are entered once, and not several times for each calculation! Parallel accounting of the presence/absence of ACS. Accounting for the presence/absence of stents in the coronary bed. Analysis of the interaction of DOACs with concomitant therapy. Which allows you to get the optimal recommendation. In addition, you are not left with the results of calculations, but immediately receive a recommendation in text form, verified with the latest recommendations. And you do not need the Internet for this! - When choosing an anticoagulant for PE/DVT, the program calculates all the necessary scales and formulas simultaneously (Geneva, Wells, PESI, Cockcroft-Gault, CKD-EPI, predictive scale of thrombosis recurrence probability, VTE-BLEED, etc.). Can take into account ACS, stenting. - Algorithm for using rivaroxaban 2.5 mg. - Collective scale for modifying the risk of bleeding (significant and insignificant). - Links to various educational events that somehow touch on the topic of anticoagulant therapy or treatment of AF (requires an Internet connection). For teachers, lecturers, students: - Allows you to easily and quickly model patients of varying complexity - Using the application, you can quickly create clinical tasks (thematic) - Can be useful in mastering recommendations For patients: - Simplified calculators for self-monitoring. - Self-educational information on atrial fibrillation, with different levels of delivery. Disclaimer. - the author does not bear any responsibility for the consequences that follow the use of the recommendations generated by the program. recommendations are advisory in nature and are not a guide to action. - if you are not a certified medical specialist, then always remember that you should never use the recommendations generated by the program without consulting a doctor! - if you are a medical specialist, then all responsibility for making a decision in a specific clinical situation lies with you (as always). The program's recommendations are only auxiliary in nature. Only you decide whether to use the information received or not. Documents: - 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) - 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation - 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation - 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation - 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants - 2020 RCS with the participation of: All-Russian Scientific Society of Specialists in Clinical Electrophysiology, Arrhythmology and Cardiac Stimulation, Association of Cardiovascular Surgeons of Russia. Clinical guidelines Atrial fibrillation and flutter. - 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) - 2018 Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function Scales: - CKD-EPI (2021) - GFR according to Cockcroft-Gault - Geneva scale (revised) - HEMORR2HAGES - ABC - Wells criteria - PESI - HAS-BLED - CHA2DS-VA - ATRIA - SCORE2, SCORE2-OP
NephX
Read full descriptionHide full description
NephX is a secure messaging platform built exclusively for the nephrology community in India. WHY NEPHX EXISTS Every brilliant case discussion, every academic insight that happens in WhatsApp threads — most of it disappears. NephX exists to preserve the collective wisdom of Indian nephrology, structured and searchable for the next consultant, the next fellow, the next decade. WHAT'S INSIDE - Case discussions with structured threads and searchable archives - Voice and video calls — one-tap, with colleagues anywhere in India - Academic meetings — host journal clubs, CME, board meetings (recorded + transcribed) - Status updates — quick clinical posts visible for 24 hours - Document and DICOM sharing — radiology, lab reports, scans - Live location for emergency consults - End-to-end encrypted transit, encrypted at rest VERIFIED DOCTORS ONLY NephX is free, but access is gated by manual verification. Our admin team verifies medical credentials against Medical Council registries before activating each account. Patient confidentiality is a first-class design constraint, not an afterthought. NOT A MEDICAL DEVICE NephX is for peer academic discussion only. It is not a medical device, not a diagnostic tool, and not intended for direct patient care. BUILT BY THE NEPHX TEAM Developed by GeeApps for the Indian nephrology community. Free forever for verified members. Questions? Dr.VelArvind Subramaiam MD., DM., Email contact@nephx.app or call +91 96266 36000.
Screenshots
Verdict
The clearest difference is update cadence: NephX at every 8 days against AK Adjutant's every 2 months. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
AK Adjutant ships an update every 2 months, NephX every 8 days. The most recent releases landed on November 3, 2026 and October 31, 2026 respectively.
| Parameter | AK Adjutant | NephX |
|---|---|---|
| Price | Free | Free |
| Positive reviews | 100.0% of reviews | — |
| Update frequency | Every 2 months | Every 8 days — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad | iPhone, iPad, Apple Watch — better |
| Requires iOS | 16.0 — better | 17.0 |
| Further details — not scored | ||
| Size | 9 MB | 123 MB |
| Age rating | 17+ | 17+ |
| Developer | Vladimir Shapovalov | Gobi Ganesan |
In-app purchases
AK Adjutant
No in-app purchases
NephX
No in-app purchases









